Invention Application
- Patent Title: THERAPEUTIC AGENT FOR TREATING CANCER COMPRISING ANTI-MIRNA-ALBUMIN COMPOSITE
-
Application No.: US16425849Application Date: 2019-05-29
-
Publication No.: US20200071698A1Publication Date: 2020-03-05
- Inventor: Sun Hwa KIM , Ick Chan KWON , Kwangmeyung KIM , Hong Yeol YOON , Gi-Jung KWAK , Juho PARK
- Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Applicant Address: KR Seoul
- Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee Address: KR Seoul
- Priority: KR10-2018-0102103 20180829
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61P35/00
Abstract:
The present invention relates to a novel anti-miRNA single-stranded nucleic acid maleimide derivative, which comprises an anti-miRNA single-stranded nucleic acid having a nucleic acid sequence complementary to a nucleic acid sequence of an miRNA. Further, the present invention provides an anti-miRNA single-stranded nucleic acid-serum albumin conjugate in which serum albumin is covalently bonded to the anti-miRNA single-stranded nucleic acid maleimide derivative via the maleimide group.
Public/Granted literature
- US11015197B2 Therapeutic agent for treating cancer comprising anti-miRNA-albumin composite Public/Granted day:2021-05-25
Information query
IPC分类:
